Fairfax, VA USA

Our News on Newswise

Practical Radiation Oncology Accepted in MEDLINE®

Practical Radiation Oncology (PRO), the official clinical practice journal of the American Society for Radiation Oncology (ASTRO), has been accepted for indexing in MEDLINE®, the U.S. National Library of Medicine’s (NLM) premier online...
4/9/2014 2:00 PM EDT

Call for entries to ASTRO’s annual Survivor Circle Award

The American Society for Radiation Oncology (ASTRO) seeks to recognize an individual cancer survivor in the San Francisco Bay area who has dedicated his or her time and energy to helping their local community.
4/4/2014 10:00 AM EDT

Dose-Escalated Hypofractionated IMRT for Localized Prostate Cancer Has Similar Side Effects When Compared to Conventional IMRT

Dose-escalated intensity modulated radiation therapy (IMRT) with use of a moderate hypofractionation regimen (72 Gy in 2.4 Gy fractions) can safely treat patients with localized prostate cancer with limited grade 2 or 3 late toxicity, according to a...
4/3/2014 2:00 PM EDT

New ASTRO White Paper Provides Guidance to Achieving Optimal Quality and Safety of High-Dose-Rate Brachytherapy

The American Society for Radiation Oncology (ASTRO) has issued a new white paper, “A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy,” that recommends specific guidance to follow in the delivery of...
3/5/2014 10:35 AM EST

Daily Humidification of the Mouth and Throat Region During Radiation Therapy for Head and Neck Cancer Reduces Mucositis and Hospitalization

Patients who received daily humidification of the mouth and throat region beginning from day one of radiation therapy treatment spent nearly 50 percent fewer days in the hospital to manage their side effects, according to research presented today at...
2/20/2014 10:00 AM EST

Data Indicates That HPV-Positive Oropharyngeal Cancer Patients Are Nearly Twice as Likely to Survive as HPV-Negative Patients

A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy in the Radiation Therapy Oncology Group (RTOG) studies 0129 or 0522 found that HPV-positive patients had a higher overall survival (OS) rate than...
2/20/2014 10:00 AM EST

Mutant-Allele Tumor Heterogeneity (MATH) in Head and Neck Squamous Cell Carcinoma Patients is an Effective Marker, Along with HPV Status, of Improved Patient Outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining...
2/20/2014 10:00 AM EST

HPV-Positive Squamous Cell Carcinoma of the Oropharynx Patients’ Recurrence Differs From HPV-Negative Patients

Patients with HPV-positive squamous cell carcinoma of the oropharynx (SCCOP) had a longer time to development of distant metastasis (DM) after initial treatment, and had more metastatic sites in more atypical locations compared to HPV-negative...
2/20/2014 10:00 AM EST

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos